Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden

Bulletin of the World Health Organization

C., N. H. (1955) · British Journal of Sociology · doi:10.2307/587237 · Cited by 3,658 · see citing works

Bulletin of the World Health Organization

Frick, K. D., Lynch, M. C., West, S. K., Muñoz, B., & Mkocha, H. A. (2003) · Bulletin of the World Health Organization · Cited by 2,656 · see citing works

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.

Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453 · see citing works

Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease

Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 335 · see citing works

Circulating vaccine-derived polioviruses: current state of knowledge.

Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 256 · see citing works

Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984

Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240 · see citing works

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

Minor, P. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.071 · Cited by 183 · see citing works

Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication

Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H. S., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 174 · see citing works

Vaccine-Associated Paralytic Poliomyelitis

Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.1987.03390100073029 · Cited by 170 · see citing works

Poliovirus vaccine-live

Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167 · see citing works

Polio eradication: the OPV paradox

Dowdle, W. R., De Gourville, E., Kew, O. M., Pallansch, M. A., & Wood, D. J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.401 · Cited by 144 · see citing works

Intramuscular Injections within 30 Days of Immunization with Oral Poliovirus Vaccine — A Risk Factor for Vaccine-Associated Paralytic Poliomyelitis

Strebel, P. M., Ion-Nedelcu, N., Baughman, A. L., Sutter, R. W., & Cochi, S. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320804 · Cited by 104 · see citing works

Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.

Kohler, K. A., Banerjee, K., Hlady, W. G., Andrus, J. K., & Sutter, R. W. (2002) · Europe PMC (PubMed Central) · Cited by 89 · see citing works

Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.

Andrus, J. K., Strebel, P. M., de Quadrós, C. A., & Olivé, J. M. (1995) · Europe PMC (PubMed Central) · Cited by 79 · see citing works

VACCINE-ASSOCIATED POLIOMYELITIS IN THE UNITED STATES, 1961–19721

Schonberger, L. B., McGowan, J. E., & Gregg, M. B. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112290 · Cited by 76 · see citing works

Paralytic poliomyelitis in England and Wales, 1985-91.

Joce, R. E., Wood, D., Brown, D., & Begg, N. T. (1992) · BMJ · doi:10.1136/bmj.305.6845.79 · Cited by 73 · see citing works

Safety of oral poliomyelitis vaccine: results of a WHO enquiry.

Esteves, K. (1988) · PubMed · Cited by 63 · see citing works

Paralytic Poliomyelitis in Romania, 1984–1992

Strebel, P. M., Aubert-Combiescu, A., Ion-Nedelcu, N., Biberi-Moroeanu, S., Combiescu, M., Sutter, R. W., Kew, O. M., Pallansch, M. A., PATRIARCA, P. A., & Cochi, S. L. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117211 · Cited by 60 · see citing works

World wide experience with inactivated poliovirus vaccine

Bonnet, M.-C., & Dutta, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.026 · Cited by 58 · see citing works

Vaccine-associated Paralytic Poliomyelitis in Immunodeficient Children, Iran, 1995–2008

Shahmahmoodi, S., Mamishi, S., Aghamohammadi, A., Aghazadeh, N., Tabatabaie, H., Gooya, M. M., Zahraei, S. M., Mousavi, T., Yousefi, M., Farrokhi, K., et al. (2010) · Emerging infectious diseases · doi:10.3201/eid1607.091606 · Cited by 47 · see citing works

PARALYTIC POLIOMYELITIS IN ENGLAND AND WALES 1976-7

Collingham, K. E. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90260-x · Cited by 47 · see citing works

Guillain Barré syndrome in a population less than 15 years old in Brazil

Dias‐Tosta, E., & Kückelhaus, C. S. (2002) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2002000300005 · Cited by 44 · see citing works

Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine

Wattigney, W. A., Mootrey, G. T., Braun, M. M., et al. (2001) · PEDIATRICS · doi:10.1542/peds.107.5.e83 · Cited by 40 · see citing works

Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations.

(2013) · PubMed · Cited by 36 · see citing works

Experiences Associated with the Use of Live Poliovirus Vaccine in Hungary, 1959–1982

Dömök, I. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s413 · Cited by 33 · see citing works

Paralytic Poliomyelitis Associated With Sabin Monovalent and Bivalent Oral Polio Vaccines in Hungary

Estívariz, C. F., Molnar, Z., Venczel, L., Kapusinszky, B., Zingeser, J. A., Lipskaya, G. Y., Kew, O. M., Berencsi, G., & Csohan, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr070 · Cited by 31 · see citing works

Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil

de Oliveira, L. H., & Struchiner, C. J. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.757 · Cited by 30 · see citing works

Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies.

Varughese, P., Carter, A. O., Acres, S. E., & Furesz, J. (1989) · PubMed · Cited by 28 · see citing works

Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany

Driesel, G., Diedrich, S., Künkel, U., & Schreier, E. (1995) · European Journal of Epidemiology · doi:10.1007/bf01720298 · Cited by 25 · see citing works

The work of the WHO Consultative Group on Poliomyelitis Vaccines.

Wc, C. (1988) · PubMed · Cited by 22 · see citing works

Surveillance of suspected poliomyelitis in Albania, 1980?1995: suggestion of increased risk of vaccine associated poliomyelitis

Diamanti, E. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80025-x · Cited by 21 · see citing works

The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group.

(1982) · Europe PMC (PubMed Central) · Cited by 20 · see citing works

Surveillance of acute flaccid paralysis in Italy: 1996–1997

Fiore, L., Novello, F., Simeoni, P., Amato, C., Vellucci, L., Stefano, D. C. D., Grandolfo, M. E., & Luzzi, I. (1999) · European Journal of Epidemiology · doi:10.1023/a:1007697421114 · Cited by 17 · see citing works

Poliomyelitis surveillance in England and Wales, 1969–1975

Smith, J. W. G., & Wherry, P. J. (1978) · Journal of Hygiene · doi:10.1017/s0022172400053481 · Cited by 17 · see citing works

Poisson-Model Analysis of the Risk of Vaccine-Associated Paralytic Poliomyelitis in Japan between 1971 and 2000

Hao, L., Toyokawa, S., & Kobayashi, Y. (2008) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2008.100 · Cited by 16 · see citing works

Vaccine-associated paralytic poliomyelitis in Brazil, 1989-1995

de Oliveira, L. H., & Struchiner, C. J. (2000) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892000000400002 · Cited by 15 · see citing works

Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en Colombia

Alvis‐Guzmán, N., de la Hoz, F., & Narváez, J. (2010) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892010000500005 · Cited by 14 · see citing works

Paralytic poliomyelitis in England & Wales, 1970–84

Begg, N. T., Chamberlain, R., & Roebuck, M. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066905 · Cited by 12 · see citing works

Ocorrência de poliomielite associada à vacina no Brasil, 1995 a 2001

Teixeira-Rocha, E. S., Carmo, E. H., & Tavares‐Neto, J. (2005) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892005000600004 · Cited by 12 · see citing works

The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.

(1976) · PubMed · Cited by 12 · see citing works

Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.

Samoilovich, E., Feldman, E. V., Yermalovich, M. A., et al. (2003) · PubMed · Cited by 8 · see citing works

Further clarity on vaccine-associated paralytic polio in India.

Kohler, K. A., Banerjee, K., & Sutter, R. W. (2002) · PubMed · Cited by 7 · see citing works

Casos de poliomielitis paralítica asociada a la vacuna oral antipoliomielítica en Cuba (1963-2006)

Lago, P. M., Ferrer, H., Goyenechea, Á., et al. (2008) · Revista cubana de higiene y epidemiología · Cited by 5 · see citing works

[Paralytic poliomyelitis in Russian Federation in 1998-2005].

Ivanova, O. E., Tp, E., Leshchinskaia, E. V., et al. (2007) · PubMed · Cited by 5 · see citing works

Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.

Ørstavik, I., Flugsrud, L. B., & Lahelle, O. (1971) · PubMed · Cited by 4 · see citing works

How objective are the supporters of the Haemoglobin Colour Scale?

Paddle, J. (2002) · PubMed · Cited by 3 · see citing works

Polio vaccination: Past, present and future

Bandyopadhyay, A. S., Garon, J., Seib, K., & Orenstein, W. A. (2015) · Future Microbiology · doi:10.2217/fmb.15.19 · Cited by 276 · see citing works

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence

Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221 · see citing works

Update on Vaccine-Derived Polioviruses-Worldwide, January 2017–June 2018

Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Sutter, R. W., Wassilak, S. G. F., & Burns, C. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6742a5 · Cited by 197 · see citing works

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: Two clinical trials

De Coster, I., Leroux-Roels, I., Bandyopadhyay, A. S., Gast, C., Withanage, K., Steenackers, K., De Smedt, P., Aerssens, A., Leroux-Roels, G., Oberste, M. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32541-1 · Cited by 86 · see citing works

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Asturias, E. J., Bandyopadhyay, A. S., Self, S., Rivera, L., Saez-Llorens, X., Lopez, E., Melgar, M., Gaensbauer, J. T., Weldon, W. C., Oberste, M. S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00703-0 · Cited by 80 · see citing works

Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication

Modlin, J. F., Bandyopadhyay, A. S., & Sutter, R. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa622 · Cited by 49 · see citing works

A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus

Korotkova, E. A., Gmyl, A. P., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Kozlovskaya, L. I., Shakaryan, A. K., Lipskaya, G. Y., Parshina, I. L., Loginovskikh, N. V., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00277-16 · Cited by 23 · see citing works

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial

Crothers, J. W., Ross Colgate, E., Cowan, K. J., Dickson, D. M., Walsh, M., Carmolli, M., Wright, P. F., Norton, E. B., & Kirkpatrick, B. D. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.056 · Cited by 18 · see citing works

The Long and Winding Road to Eradicate Vaccine-Related Polioviruses

Cochi, S. L., & Pallansch, M. A. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa393 · Cited by 9 · see citing works

No Evidence of HIV and SIV Sequences in Two Separate Lots of Polio Vaccines Used in the First U.S. Polio Vaccine Campaign

Rizzo, P., Matker, C., Powers, A. A., et al. (2001) · Virology · doi:10.1006/viro.2001.0955 · Cited by 2 · see citing works

Use of mutational pattern in 5′-NCR and VP1 regions of polioviruses for molecular diagnosis

Pliaka, V., Dedepsidis, E., Kyriakopoulou, Z., Papadopoulou, I., Levidiotou, S., & Markoulatos, P. (2007) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2007.01.004 · Cited by 8 · see citing works

Characterization of mutations in the VP1 region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran

Rahimi, P., Tabatabaie, H., Gouya, M. M., Zahraie, M., Mahmudi, M., Ziaie, A., Samimi‐Rad, K., Shahmahmudi, S., Musavi, T., Mokhtari‐Azad, T., et al. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.04.017 · Cited by 8 · see citing works

Strengthened surveillance revealed a rapid disappearance of the poliovirus serotype 2 vaccine strain in Madagascar after its removal from the oral polio vaccine

Razafindratsimandresy, R., Joffret, M., Raharinantoanina, J., Polston, P. M., Andriamamonjy, S., Razanajatovo, I. M., Diop, O. M., Delpeyroux, F., Héraud, J., & Bessaud, M. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28071 · Cited by 1 · see citing works

The Pathology of Poliomyelitis and the Vaccines and Nonvaccine Therapy

Chen, Y., Yue, T., & Zhang, Z. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202130802018 · Cited by 3 · see citing works